Pasithea Stock Plunges 14.14% Amid CEO Share Sale

Generado por agente de IAAinvest Pre-Market Radar
jueves, 15 de mayo de 2025, 7:34 am ET1 min de lectura
KTTA--

On May 15, 2025, Pasithea's stock price plummeted by 14.14% during pre-market trading, sparking concerns among investors about the company's recent developments.

Pasithea Therapeutics' CEO, Tiago Marques, recently sold shares worth $792, which has raised eyebrows among market observers. This transaction has added to the uncertainty surrounding the company's future prospects, potentially contributing to the significant drop in its stock price.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios